Biotechnology company developing therapeutic candidates targeting drug-resistant and devastating cancers using ferroptosis
ehealth radio network

Biotechnology company developing therapeutic candidates targeting drug-resistant and devastating cancers using ferroptosis

2023-05-23
    Randy Milby, the Chief Executive Officer and Chairman of Hillstream BioPharma, a biotechnology company developing therapeutic candidates targeting drug-resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resulting in iron mediated cell death, and immuno-oncology targeted novel biologics joins eHealth Radio and the Cancer Information & Health News Channels. Listen to interview with host Eric Michaels and guest Randy Milby discuss the fo...
View more
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Create Your Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free